Science Explorer Back to mapMap

Most cited papers in Neurological Complications and Syndromes

Neurological Complications and Syndromes

What are the most cited papers in Neurological Complications and Syndromes?

The most cited paper in Neurological Complications and Syndromes is "A Reversible Posterior Leukoencephalopathy Syndrome" (Judy Hinchey, Claudia J Chaves, B A Appignani et al., 1996), with 3,350 citations. Next come "Migraine prevalence, disease burden, and the need for preventive therapy" (2,375) and "Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II" (2,285).

Showing 50 of 100 papers. Every paper with more than 565 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 A Reversible Posterior Leukoencephalopathy Syndrome Judy Hinchey, Claudia J Chaves, B A Appignani et al. · New England Journal of Medicine 22 Feb 1996 3,350
2 Migraine prevalence, disease burden, and the need for preventive therapy Richard B. Lipton, MARCELO EDUARDO BIGAL, Merle L. Diamond et al. · Neurology Open access 30 Jan 2007 2,375
3 Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II Richard B. Lipton, Walter F. Stewart, Seymour Diamond et al. · Headache The Journal of Head and Face Pain 12 Jul 2001 2,285
4 Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years Anthony S. Fauci, Barton F. Haynes, Paul Katz et al. · Annals of Internal Medicine 1983 2,022
5 Homocysteine and Atherothrombosis George N. Welch, Joseph Loscalzo · New England Journal of Medicine 9 Apr 1998 2,017
6 Moyamoya Disease and Moyamoya Syndrome R. Michael Scott, Edward R. Smith · New England Journal of Medicine 18 Mar 2009 1,780
7 Cerebrovascular "Moyamoya" Disease Jirô Suzuki, Namio Kodama · Angiology Apr 1971 1,635
8 Prevalence of Migraine Headache in the United States Walter F. Stewart · JAMA 1992 1,514
9 MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS H. W. SOLLINGER · Transplantation Aug 1995 1,384
10 Incidence and Prognosis of Syncope Elpidoforos Soterakis Soteriades, Jane Cooper Evans, Martin G. Larson et al. · New England Journal of Medicine 18 Sep 2002 1,328
11 Diabetes Mellitus after Kidney Transplantation in the United States Bertram L. Kasiske, Jon J. Snyder, David T. Gilbertson et al. · American Journal of Transplantation Open access Feb 2003 1,298
12 CD39 and CD73 in immunity and inflammation Luca Antonioli, Pál Pacher, E. Sylvester Vizi et al. · Trends in Molecular Medicine ReviewOpen access 17 Apr 2013 1,284
13 Moyamoya disease: current concepts and future perspectives Satoshi Kuroda, Kiyohiro Houkin · The Lancet Neurology 15 Oct 2008 1,215
14 Cyclosporine-Associated Chronic Nephropathy Bryan D. Myers, Jon C. Ross, Lynn Newton et al. · New England Journal of Medicine 13 Sep 1984 1,170
15 Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade Gennady G. Yegutkin · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Open access 13 Feb 2008 1,170
16 The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation Camille N. Kotton, Deepali Kumar, Angela M. Caliendo et al. · Transplantation Open access 29 Mar 2018 1,164
17 Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions Jennifer E. Fugate, Alejandro A. Rabinstein · The Lancet Neurology 13 Jul 2015 1,156
18 Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features Walter S. Bartynski · American Journal of Neuroradiology Open access 20 Mar 2008 1,100
19 FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION ThomasE. Starzl, John J. Fung, Raman Venkataramman et al. · The Lancet Open access Oct 1989 1,057
20 Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema Walter S. Bartynski · American Journal of Neuroradiology Open access 10 Apr 2008 1,044
21 Core assessment program for intracerebral transplantations (CAPIT) J. William Langston, Håkan Widner, Christopher G. Goetz et al. · Movement Disorders 1992 1,014
22 CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS R. Y. Calne, Shankar S. Thiru, P. E. McMaster et al. · The Lancet Dec 1978 1,014
23 The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients Anne Ducros, Monique Boukobza, Raphaël Porcher et al. · Brain 3 May 2007 1,013
24 Migraine as a Risk Factor for Subclinical Brain Lesions Mark C. Kruit · JAMA 27 Jan 2004 1,004
25 Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials Michel D. Ferrari, Krista I Roon, Richard B. Lipton et al. · The Lancet Review Nov 2001 992
26 Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis) Research Committee on the Pathology and Treatment of Spontaneous Occlusion of th, Health Labour Sciences Research Grant for Research on Measures for Intractable D · Neurologia medico-chirurgica Open access 2012 986
27 Narrative Review: Reversible Cerebral Vasoconstriction Syndromes Leonard H. Calabrese, David W. Dodick, Todd J. Schwedt et al. · Annals of Internal Medicine Review 2 Jan 2007 954
28 The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates Lars Jacob Stovner, Knut Hagen, Mattias Linde et al. · The Journal of Headache and Pain Open access 11 Apr 2022 937
29 Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses Sarah D. McDonald, Ann Kinga Malinowski, Qi Xin Zhou et al. · American Heart Journal Review 3 Oct 2008 933
30 Burden of Migraine in the United States Xiaohan Hu, Leona E. Markson, Richard B. Lipton et al. · Archives of Internal Medicine Open access 26 Apr 1999 919
31 Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Stephen D. Silberstein, Starr Holland, F. G. Freitag et al. · Neurology Open access 23 Apr 2012 910
32 Posterior Reversible Encephalopathy Syndrome: Associated Clinical and Radiologic Findings Jennifer E. Fugate, Daniel O. Claassen, Harry J. Cloft et al. · Mayo Clinic Proceedings Open access 30 Apr 2010 909
33 Moyamoya disease--a review. Jirô Suzuki, Namio Kodama · Stroke 1983 902
34 EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force Stefan Evers, Judit Áfra, Achim Frese et al. · European Journal of Neurology 7 Aug 2009 899
35 Purinergic signalling in neuron–glia interactions R. Douglas Fields, Geoffrey Burnstock · Nature reviews. Neuroscience ReviewOpen access 19 May 2006 864
36 Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study MARCELO EDUARDO BIGAL, Daniel Serrano, Dawn C. Buse et al. · Headache The Journal of Head and Face Pain Sep 2008 861
37 Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine Jes Olesen, Bo Larsen, Martin Lauritzen · Annals of Neurology Apr 1981 859
38 Posterior Reversible Encephalopathy Syndrome: Incidence of Atypical Regions of Involvement and Imaging Findings Alexander M. McKinney, James H. Short, Charles L. Truwit et al. · American Journal of Roentgenology 20 Sep 2007 850
39 Migraine and cardiovascular disease: systematic review and meta-analysis Markus Schürks, Pamela M. Rist, ME Bigal et al. · BMJ ReviewOpen access 27 Oct 2009 850
40 Strategies to Improve Long-Term Outcomes after Renal Transplantation Manuel A. Pascual, Tom P. Theruvath, Tatsuo Kawai et al. · New England Journal of Medicine 21 Feb 2002 842
41 Reversible cerebral vasoconstriction syndrome Anne Ducros · The Lancet Neurology 17 Sep 2012 838
42 Fremanezumab for the Preventive Treatment of Chronic Migraine Stephen David Silberstein, David W. Dodick, MARCELO EDUARDO BIGAL et al. · New England Journal of Medicine Open access 24 Nov 2017 824
43 Delayed Graft Function in the Kidney Transplant Andrew M. Siedlecki, William D Irish, Daniel C. Brennan · American Journal of Transplantation Open access 19 Sep 2011 818
44 Long-term survival in renal transplant recipients with graft function AKINLOLU O. OJO, Julie A. Hanson, Robert A. Wolfe et al. · Kidney International Open access 2000 816
45 Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis Kirsten de Groot, Niels Rasmussen, PAUL A. BACON et al. · Arthritis & Rheumatism 28 Jul 2005 800
46 Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association Donna Marie Ferriero, Heather J. Fullerton, Timothy J. Bernard et al. · Stroke Open access 28 Jan 2019 794
47 SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY IN AN INFANT Denis Leigh · Journal of Neurology Neurosurgery & Psychiatry Open access Aug 1951 794
48 Risk Factors for Cytomegalovirus Infection after Human Marrow Transplantation J D Meyers, Nancy Flournoy, E. Donnall Thomas · The Journal of Infectious Diseases Mar 1986 786
49 Purinergic regulation of the immune system Caglar Cekic, Joel M Linden · Nature reviews. Immunology Review 29 Feb 2016 785
50 The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice Jessica Ailani, Rebecca C. Burch, Matthew S. Robbins et al. · Headache The Journal of Head and Face Pain 23 Jun 2021 779

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.